265 related articles for article (PubMed ID: 26831335)
1. Greater improvement in LRRK2 G2019S patients undergoing Subthalamic Nucleus Deep Brain Stimulation compared to non-mutation carriers.
Sayad M; Zouambia M; Chaouch M; Ferrat F; Nebbal M; Bendini M; Lesage S; Brice A; Brahim Errahmani M; Asselah B
BMC Neurosci; 2016 Feb; 17():6. PubMed ID: 26831335
[TBL] [Abstract][Full Text] [Related]
2. The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease.
Greenbaum L; Israeli-Korn SD; Cohen OS; Elincx-Benizri S; Yahalom G; Kozlova E; Strauss H; Molshatzki N; Inzelberg R; Spiegelmann R; Israel Z; Hassin-Baer S
Parkinsonism Relat Disord; 2013 Nov; 19(11):1053-6. PubMed ID: 23932063
[TBL] [Abstract][Full Text] [Related]
3. Sustained response to deep brain stimulation in LRRK2 parkinsonism with the Y1699C mutation.
Perju-Dumbrava LD; McDonald M; Kneebone AC; Long R; Thyagarajan D
J Parkinsons Dis; 2012; 2(4):269-71. PubMed ID: 23938256
[TBL] [Abstract][Full Text] [Related]
4. Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism.
Moro E; Volkmann J; König IR; Winkler S; Hiller A; Hassin-Baer S; Herzog J; Schnitzler A; Lohmann K; Pinsker MO; Voges J; Djarmatic A; Seibler P; Lozano AM; Rogaeva E; Lang AE; Deuschl G; Klein C
Neurology; 2008 Apr; 70(14):1186-91. PubMed ID: 18378882
[TBL] [Abstract][Full Text] [Related]
5. Analysis of deep brain stimulation of the subthalamic nucleus (STN-DBS) in patients with monogenic PRKN and LRRK2 forms of Parkinson's disease.
Prendes Fernández P; Blázquez Estrada M; Sol Álvarez J; Álvarez Martínez V; Suárez San Martín E; García Fernández C; Álvarez Carriles JC; Lozano Aragoneses B; Saiz Ayala A; Santamarta Liébana E; González Álvarez L
Parkinsonism Relat Disord; 2023 Feb; 107():105282. PubMed ID: 36657280
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
7. Different effectiveness of subthalamic deep brain stimulation in Parkinson's disease: A comparative cohort study at 1 year and 5 years.
Jiang JL; Chen SY; Hsieh TC; Lee CW; Lin SH; Tsai ST
J Formos Med Assoc; 2015 Sep; 114(9):835-41. PubMed ID: 24103710
[TBL] [Abstract][Full Text] [Related]
8. Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.
Nabli F; Ben Sassi S; Amouri R; Duda JE; Farrer MJ; Hentati F
Mov Disord; 2015 Feb; 30(2):253-8. PubMed ID: 25487881
[TBL] [Abstract][Full Text] [Related]
9. [Significant improvement of motor symptoms by deep brain stimulation of bilateral subthalamic nucleus in patients with moderate or advanced Parkinson's disease].
Chen J; Liu JL; Chen X; Qian H; Xian WB; Zhou HY; Liu YM; Ye XF; Zheng YF; Zhang SL; Chen L; Li JR; Liu ZL; Pei Z
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):291-5. PubMed ID: 21419000
[TBL] [Abstract][Full Text] [Related]
10. Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease.
Ben Sassi S; Nabli F; Hentati E; Nahdi H; Trabelsi M; Ben Ayed H; Amouri R; Duda JE; Farrer MJ; Hentati F
Parkinsonism Relat Disord; 2012 Mar; 18(3):243-6. PubMed ID: 22056842
[TBL] [Abstract][Full Text] [Related]
11. Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.
Schüpbach M; Lohmann E; Anheim M; Lesage S; Czernecki V; Yaici S; Worbe Y; Charles P; Welter ML; Pollak P; Dürr A; Agid Y; Brice A
Mov Disord; 2007 Jan; 22(1):119-22. PubMed ID: 17080443
[TBL] [Abstract][Full Text] [Related]
12. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
[TBL] [Abstract][Full Text] [Related]
13. Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic parkinson's disease: one year follow-up.
Pinter MM; Alesch F; Murg M; Seiwald M; Helscher RJ; Binder H
J Neural Transm (Vienna); 1999; 106(7-8):693-709. PubMed ID: 10907728
[TBL] [Abstract][Full Text] [Related]
14. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results.
Harries AM; Kausar J; Roberts SA; Mocroft AP; Hodson JA; Pall HS; Mitchell RD
J Neurosurg; 2012 Jan; 116(1):107-13. PubMed ID: 21999316
[TBL] [Abstract][Full Text] [Related]
15. Outcome of bilateral deep brain subthalamic stimulation in patients carrying the R1441G mutation in the LRRK2 dardarin gene.
Gómez-Esteban JC; Lezcano E; Zarranz JJ; González C; Bilbao G; Lambarri I; Rodríguez O; Garibi J
Neurosurgery; 2008 Apr; 62(4):857-62; discussion 862-3. PubMed ID: 18496192
[TBL] [Abstract][Full Text] [Related]
16. [Effects of bilateral deep brain stimulation in the subthalamic nucleus using two methods of target structure verification].
Goubareva NN; Fedorova NV; Bril' EV; Tomskiy AA; Gamaleya AA; Poddubskaya AA; Shabalov VA; Omarova SM
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):24-30. PubMed ID: 29265083
[TBL] [Abstract][Full Text] [Related]
17. Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis.
Artusi CA; Dwivedi AK; Romagnolo A; Pal G; Kauffman M; Mata I; Patel D; Vizcarra JA; Duker A; Marsili L; Cheeran B; Woo D; Contarino MF; Verhagen L; Lopiano L; Espay AJ; Fasano A; Merola A
JAMA Netw Open; 2019 Feb; 2(2):e187800. PubMed ID: 30707228
[TBL] [Abstract][Full Text] [Related]
18. Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations.
Mangone G; Bekadar S; Cormier-Dequaire F; Tahiri K; Welaratne A; Czernecki V; Pineau F; Karachi C; Castrioto A; Durif F; Tranchant C; Devos D; Thobois S; Meissner WG; Navarro MS; Cornu P; Lesage S; Brice A; Welter ML; Corvol JC;
Parkinsonism Relat Disord; 2020 Jul; 76():56-62. PubMed ID: 32866938
[TBL] [Abstract][Full Text] [Related]
19. Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation.
Yahalom G; Kaplan N; Vituri A; Cohen OS; Inzelberg R; Kozlova E; Korczyn AD; Rosset S; Friedman E; Hassin-Baer S
Parkinsonism Relat Disord; 2012 Nov; 18(9):1039-41. PubMed ID: 22703868
[TBL] [Abstract][Full Text] [Related]
20. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease.
Slowinski JL; Putzke JD; Uitti RJ; Lucas JA; Turk MF; Kall BA; Wharen RE
J Neurosurg; 2007 Apr; 106(4):626-32. PubMed ID: 17432714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]